ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.856,48
-0,77%
S&P 500
5.827,04
-1,54%
US Dollar vs BRL
6,12417
0,00%
Bitcoin
94.475,41
-0,24%
Brent Oil
79,285
0,00%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Royalty Pharma PLC (RPRX)

  7. Royalty Pharma PLC (RPRX) Notícias

RPRX

Royalty Pharma (RPRX)

Royalty Pharma PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RPRX
DataHoraFonteTítuloCódigoCompanhia
10/01/202519:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RPRXRoyalty Pharma PLC
10/01/202519:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
10/01/202509:30GlobeNewswire Inc.Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
10/01/202509:15GlobeNewswire Inc.Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase ProgramNASDAQ:RPRXRoyalty Pharma PLC
09/01/202518:15GlobeNewswire Inc.Royalty Pharma Announces Dividend IncreaseNASDAQ:RPRXRoyalty Pharma PLC
27/11/202418:15GlobeNewswire Inc.Royalty Pharma to Present at Upcoming Investor ConferencesNASDAQ:RPRXRoyalty Pharma PLC
14/11/202418:30GlobeNewswire Inc.Royalty Pharma Announces Inaugural Prize for Impact in HealthcareNASDAQ:RPRXRoyalty Pharma PLC
07/11/202409:10GlobeNewswire Inc.Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 MillionNASDAQ:RPRXRoyalty Pharma PLC
06/11/202411:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
06/11/202409:15GlobeNewswire Inc.Royalty Pharma Reports Third Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
04/11/202418:15GlobeNewswire Inc.Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for NiktimvoNASDAQ:RPRXRoyalty Pharma PLC
04/11/202418:01PR Newswire (US)Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™NASDAQ:RPRXRoyalty Pharma PLC
16/10/202417:15GlobeNewswire Inc.Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:RPRXRoyalty Pharma PLC
11/10/202409:15GlobeNewswire Inc.Royalty Pharma Declares Fourth Quarter 2024 DividendNASDAQ:RPRXRoyalty Pharma PLC
03/09/202418:14GlobeNewswire Inc.Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
03/09/202418:06GlobeNewswire Inc.Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
28/08/202417:15GlobeNewswire Inc.Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
12/08/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
08/08/202408:00GlobeNewswire Inc.Royalty Pharma Reports Second Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
29/07/202417:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RPRXRoyalty Pharma PLC
24/07/202409:30GlobeNewswire Inc.Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human CapitalNASDAQ:RPRXRoyalty Pharma PLC
19/07/202409:15GlobeNewswire Inc.Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:RPRXRoyalty Pharma PLC
17/07/202417:15GlobeNewswire Inc.Royalty Pharma Declares Third Quarter 2024 DividendNASDAQ:RPRXRoyalty Pharma PLC
04/06/202418:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RPRXRoyalty Pharma PLC
04/06/202417:15GlobeNewswire Inc.Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
03/06/202418:15GlobeNewswire Inc.Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured NotesNASDAQ:RPRXRoyalty Pharma PLC
03/06/202417:59Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:RPRXRoyalty Pharma PLC
03/06/202409:39Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:RPRXRoyalty Pharma PLC
28/05/202408:10GlobeNewswire Inc.Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 MillionNASDAQ:RPRXRoyalty Pharma PLC
22/05/202417:10GlobeNewswire Inc.Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D PipelineNASDAQ:RPRXRoyalty Pharma PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:RPRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BRAV3
Brava Energia ON
BOV
AMOB3
Automob Participacoes ON
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados